肺表面活性物质治疗急性呼吸窘迫综合征研究现状

Current status of pulmonary surfactant in the treatment of acute respiratory distress syndrome

肺表面活性物质(pulmonary surfactant,PS)是急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS)的治疗手段之一,但治疗效果尚不明确。相关研究表明,不同种类的PS、给药剂量、给药方式等因素均可能影响PS使用效果。该文对PS治疗ARDS的研究现状进行概述。

Pulmonary surfactant（PS）is one of the treatments for acute respiratory distress syndrome（ARDS）,but the curative effect is still unsure. The results of current studies indicate that different kinds,doses and delivery methods of PS may affect the outcomes. This paper makes a review of the current status of PS in the treatment of ARDS.